{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:48:26Z","timestamp":1784738906288,"version":"3.55.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to systematically investigate gene signatures for hepatoblastoma (HB) and identify potential biomarkers for its diagnosis and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>GSE131329 and GSE81928 were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) between hepatoblastoma and normal samples were identified using the Limma package in R. Then, the similarity of network traits between two sets of genes was analyzed by weighted gene correlation network analysis (WGCNA). Cytoscape was used to visualize and select hub genes. PPI network of hub genes was construed by Cytoscape. GO enrichment and KEGG pathway analyses of hub genes were carried out using ClueGO. The random forest classifier was constructed based on the hub genes using the GSE131329 dataset as the training set, and its reliability was validated using the GSE81928 dataset. The resulting core hub genes were combined with the InnateDB database to identify the innate core genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 4244 DEGs in HB were identified. WGCNA identified four modules that were significantly correlated with the disease status. A total of 114 hub genes were obtained within the top 20 genes of each node rank. 6982 relation pairs and 3700 nodes were contained in the PPI network of 114 hub genes. GO enrichment and KEGG pathway analyses of hub genes were focused on MAPK, cell cycle, p53, and other crucial pathways involved in HB. A random forest classifier was constructed using the 114 hub genes as feature genes, resulting in a 95.5% true positive rate when classifying HB and normal samples. A total of 35 core hub genes were obtained through the mean decrease in accuracy and mean decrease Gini of the random forest model. The classification efficiency of the random forest model was 81.4%. Finally, <jats:italic>CDK1<\/jats:italic>, <jats:italic>TOP2A<\/jats:italic>, <jats:italic>ADRA1A<\/jats:italic>, <jats:italic>FANCI<\/jats:italic>, <jats:italic>XRCC1<\/jats:italic>, <jats:italic>TPX2<\/jats:italic>, <jats:italic>CCNB2<\/jats:italic>, <jats:italic>CDK4<\/jats:italic>, <jats:italic>GLYATL1<\/jats:italic>, and <jats:italic>CFHR3<\/jats:italic> were identified by cross-comparison with the InnateDB database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study established a random forest classifier that identified 10 core genes in HB. These findings may be beneficial for the diagnosis, prediction, and targeted therapy of HB.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.591507","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T08:23:18Z","timestamp":1617265398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Rui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/mop.0000000000000081","article-title":"Management of hepatoblastoma: an update","volume":"26","author":"Kremer","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.29672","article-title":"New insights into diagnosis and therapeutic options for proliferative hepatoblastoma","volume":"68","author":"Hooks","year":"2018","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.025","article-title":"Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications","volume":"73","author":"Carrillo-Reixach","year":"2020","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-016-3960-8","article-title":"Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: A Chinese population-based study","volume":"32","author":"Liu","year":"2016","journal-title":"Pediatr Surg Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12943-019-1119-7","article-title":"m(6)A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma","volume":"18","author":"Liu","year":"2019","journal-title":"Mol Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00271","article-title":"The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF\/c-Met Pathway","volume":"7","author":"Cui","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7150\/thno.29515","article-title":"CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis","volume":"9","author":"Zhen","year":"2019","journal-title":"Theranostics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2278","DOI":"10.1038\/cddis.2016.143","article-title":"Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma","volume":"7","author":"Dong","year":"2016","journal-title":"Cell Death Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s42003-018-0077-8","article-title":"PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma","volume":"1","author":"Valanejad","year":"2018","journal-title":"Commun Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp053","article-title":"Testing significance relative to a fold-change threshold is a TREAT","volume":"25","author":"McCarthy","year":"2009","journal-title":"Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/s41467-018-04406-2","article-title":"Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation","volume":"9","author":"Ji","year":"2018","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i26.3392","article-title":"Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis","volume":"25","author":"Liang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6581576","article-title":"Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value","volume":"2019","author":"Zhou","year":"2019","journal-title":"BioMed Res Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: An R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.42","article-title":"The KEGG databases at GenomeNet","volume":"30","author":"Kanehisa","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jprot.2017.03.016","article-title":"Comprehensive functional analysis of large lists of genes and proteins","volume":"171","author":"Mlecnik","year":"2018","journal-title":"J Proteomics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6351","article-title":"Random forest classification of etiologies for an orphan disease","volume":"34","author":"Speiser","year":"2015","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-4-117","article-title":"Curating the innate immunity interactome","volume":"4","author":"Lynn","year":"2010","journal-title":"BMC Syst Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12859-016-0900-5","article-title":"An experimental study of the intrinsic stability of random forest variable importance measures","volume":"17","author":"Wang","year":"2016","journal-title":"BMC Bioinf"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm1606","article-title":"Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC","volume":"13","author":"Goga","year":"2007","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(98)00151-7","article-title":"Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas","volume":"131","author":"Kim","year":"1998","journal-title":"Cancer Lett"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat Rev Drug Discovery"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: a critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","article-title":"Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance","volume":"443","author":"Xie","year":"2019","journal-title":"Cancer Lett"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature06046","article-title":"Cdk1 is sufficient to drive the mammalian cell cycle","volume":"448","author":"Santamar\u00eda","year":"2007","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"O\u2019Leary","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.07.002","article-title":"CDK4\/6 Inhibition in Cancer: Beyond Cell Cycle Arrest","volume":"28","author":"Goel","year":"2018","journal-title":"Trends Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/erc-12-0403","article-title":"TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma","volume":"20","author":"Jain","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23968","article-title":"TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance","volume":"124","author":"Wong","year":"2009","journal-title":"Int J Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1080\/15592294.2019.1709267","article-title":"Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma","volume":"15","author":"Chen","year":"2020","journal-title":"Epigenetics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001450","article-title":"Genome-wide scan of reading ability in affected sibling pairs with attention-deficit\/hyperactivity disorder: unique and shared genetic effects","volume":"9","author":"Loo","year":"2004","journal-title":"Mol Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8465","article-title":"Clinical significance of expression levels of serum ADRA1A in hysterocarcinoma patients","volume":"15","author":"Peng","year":"2018","journal-title":"Oncol Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6522","article-title":"XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients","volume":"14","author":"Guan","year":"2017","journal-title":"Oncol Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0206853","DOI":"10.1371\/journal.pone.0206853","article-title":"Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies","volume":"13","author":"Xiong","year":"2018","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4371","article-title":"TPX2 silencing exerts anti\u2212tumor effects on hepatocellular carcinoma by regulating the PI3K\/AKT signaling pathway","volume":"44","author":"Huang","year":"2019","journal-title":"Int J Mol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3730-9","article-title":"TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT","volume":"60","author":"Liang","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12428","article-title":"TPX2 as a novel prognostic biomarker for hepatocellular carcinoma","volume":"45","author":"Liu","year":"2015","journal-title":"Hepatol Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7691","article-title":"Karyopherin subunit-\u03b1 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol Lett"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20181441","article-title":"Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma","volume":"38","author":"Gao","year":"2018","journal-title":"Biosci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2019.03.003","article-title":"Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated\u00a0with Poor Prognosis","volume":"50","author":"Li","year":"2019","journal-title":"Arch Med Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00848","article-title":"High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B","volume":"9","author":"Pouw","year":"2018","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29551","article-title":"CFHR3 is a potential novel biomarker for hepatocellular carcinoma","volume":"121","author":"Liu","year":"2020","journal-title":"J Cell Biochem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10514","article-title":"Complement factor H\u2212related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis","volume":"20","author":"Liu","year":"2019","journal-title":"Mol Med Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811557116","article-title":"Fanconi anemia protein FANCI functions in ribosome biogenesis","volume":"116","author":"Sondalle","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S230333","article-title":"FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK\/ERK\/MMPs Pathway","volume":"13","author":"Zheng","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41420-019-0185-3","article-title":"CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI","volume":"5","author":"Hu","year":"2019","journal-title":"Cell Death Discovery"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23887","article-title":"Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer","volume":"79","author":"Eich","year":"2019","journal-title":"Prostate"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2015.06.081","article-title":"Conservation of the coding regions of the glycine N-acyltransferase gene further suggests that glycine conjugation is an essential detoxification pathway","volume":"571","author":"van der Sluis","year":"2015","journal-title":"Gene"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22425","article-title":"Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome","volume":"55","author":"Nalla","year":"2016","journal-title":"Mol Carcinog"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30680","article-title":"Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer","volume":"140","author":"Wang","year":"2017","journal-title":"Int J Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12943-018-0762-8","article-title":"Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis","volume":"17","author":"Mur","year":"2018","journal-title":"Mol Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/2159-8290.Cd-12-0353","article-title":"Cancer-Specific requirement for BUB1B\/BUBR1 in human brain tumor isolates and genetically transformed cells","volume":"3","author":"Ding","year":"2013","journal-title":"Cancer Discovery"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800667R","article-title":"Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26816","article-title":"Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer","volume":"234","author":"Zhang","year":"2018","journal-title":"J Cell Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108949","article-title":"Downregulation of Cdc6 inhibits tumorigenesis of osteosarcoma in vivo and in vitro","volume":"115","author":"Jiang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S222854","article-title":"miR-30a-3p Targets MAD2L1 and Regulates Proliferation of Gastric Cancer Cells","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12885-018-4056-8","article-title":"MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S\/G2 cell cycle progression","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-17-3822","article-title":"Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia","volume":"78","author":"Merrick","year":"2018","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.023","article-title":"Mutant p53 as a target for cancer treatment","volume":"83","author":"Duffy","year":"2017","journal-title":"Eur J Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-15-0563","article-title":"p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/modpathol.3800977","article-title":"Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations","volume":"21","author":"Curia","year":"2008","journal-title":"Mod Pathol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1053\/j.gastro.2009.11.008","article-title":"Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis","volume":"138","author":"Teoh","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.591507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T08:23:27Z","timestamp":1617265407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.591507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":64,"alternative-id":["10.3389\/fonc.2021.591507"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.591507","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"article-number":"591507"}}